HPTN 082

HPTN 027

IPCAVD 001

VRC 606

Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults (CHARM-03)

HVTN 703 / HPTN 081 (The AMP Study)

Pre-exposure prevention of viral entry (PREVENT)

HVTN 704/HPTN 085 (The AMP Study)

Evaluating the Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Healthy, HIV-Uninfected Adolescents (CHAMPS Pilot Study B)

HIV-V-A002 (MENSCH)